Search alternatives:
drugs » drug (Expand Search)
Showing 1 - 20 results of 458 for search '"Drugs Testing."', query time: 0.42s Refine Results
  1. 1
    Guidance for industry : CGMP for phase 1 investigational drugs.
    Published 2008
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document eBook
  2. 2
    Concepts and strategies in new drug development /
    Published 1983
    Subjects: “...Drugs Testing....”
    Book
  3. 3
    Guidance for industry : S8 immunotoxicity studies for human pharmaceuticals.
    Published 2006
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  4. 4
    Guidance for industry : E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs.
    Published 2005
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  5. 5
    Guidance for industry : S6 preclinical safety evaluation of biotechnology-derived pharmaceuticals.
    Published 1997
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  6. 6
    Drug safety evaluation /
    by Gad, Shayne C., 1948-
    Published 2002
    Subjects: “...Drugs Testing....”
    Book
  7. 7
    The evaluation of surrogate endpoints /
    Published 2005
    Subjects: “...Drugs Testing....”
    Book
  8. 8
    Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.
    Published 2008
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  9. 9
    Visita radial a ClinicalTrials.gov : preguntas y respuestas.
    Published 2009
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Book
  10. 10
    Guidance for industry : tropical disease priority review vouchers.
    Published 2008
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document eBook
  11. 11
    Guidance for industry : Q1A(R2) stability testing of new drug substances and products.
    Published 2003
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  12. 12
    Guidance for industry : Q1D bracketing and matrixing designs for stability testing of new drug substances and products.
    Published 2003
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  13. 13
    S2(R1) genotoxicity testing and data interpretation for pharmaceuticals intended for human use.
    Published 2008
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  14. 14
    Guidance for industry : S1B testing for carcinogenicity of pharmaceuticals.
    Published 1997
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  15. 15
    Pharmacokinetics : guidance for repeated dose tissue distribution studies.
    Published 1995
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  16. 16
    Addendum to ICH S6 : preclinical safety evaluation of biotechnology-derived pharmaceuticals.
    Published 2009
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  17. 17
    Guidance for industry : estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers.
    Published 2005
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document eBook
  18. 18
    Drug bioequivalence : a report of the Office of Technology Assessment, Drug Bioequivalence Study Panel.
    Subjects: “...Drugs Testing....”
    Connect to the full text of this electronic book
    Government Document eBook
  19. 19
    Guidance for industry : Q3C impurities, residual solvents.
    Published 1997
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
  20. 20
    Guidance for industry : S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals.
    Published 2005
    Subjects: “...Drugs Testing....”
    Get full text
    Government Document Conference Proceeding eBook
Search Tools: RSS Feed – Email Search